Lost your password?
Home

neuropsychopharmacology

This shows a person with pills in their hand

Common antidepressants interact with opioid med to lessen pain relief

Neuroscience News
SSRI antidepressants, such as Prozac and Paxil, interact with opioid medications to make them less effective at providing relief from chronic pain. Tramadol relies on activation of the CYP2D6 enzyme to control pain, but SSRIs inhibit this enzyme. Researchers suggest prescribing different classes of antidepressants which do not suppress the enzyme may benefit those in need of opioid medications. Alternatively, non-opioid pain killers should be considered for those who can not switch from SSRIs.... Read More...
FeaturedNeurologyNeuroscienceOpen Neuroscience ArticlesPsychology6 min read
This shows two heads with a psychedelic background

‘Ecstasy’ shows promise for post-traumatic stress treatment

Neuroscience News
MDMA shows promise for the treatment of post-traumatic stress disorder. Combining the use of Ecstasy with psychotherapy treatments resulted in a reduction of PTSD symptoms after just one session. 54% of the study participants no longer met the PTSD criteria after two sessions. Patients also reported improvements in depression symptoms.... Read More...
FeaturedNeuroscienceOpen Neuroscience ArticlesPsychology5 min read
This is a vial of ketamine

Ketamine: The illicit party psychedelic that promises to heal depression

Neuroscience News
Ketamine, an anesthetics which has been commonly used as an illicit party drug, is helping people overcome depression. The drug works rapidly and provides lasting relief from depressive symptoms for weeks after exposure. Researchers are examining how ketamine works in the brain to help positively influence behavior in those with mood disorders.... Read More...
FeaturedNeurosciencePsychology7 min read
This shows a brain overlayed on a person's head with a swirly, psychedelic background

Psychedelic drug MDMA may reawaken ‘critical period’ in brain to help treat PTSD

Neuroscience News
MDMA, a psychedelic drug, has successfully been used to reopen the 'critical period' of learning the reward values of social behaviors. Researchers report, in mature mice given MDMA, oxytocin triggers signaling in synapses that help encode social learning and memory, a process that does not usually occur in older animals. The findings could help in the development of treatments for PTSD and other disorders.... Read More...
FeaturedNeurosciencePsychology7 min read